Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
about
Improved prediction of complex diseases by common genetic markers: state of the art and further perspectivesPromise of personalized omics to precision medicineThe emerging paradigm of network medicine in the study of human diseaseAcquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015Future translational applications from the contemporary genomics era: a scientific statement from the American Heart AssociationFinding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it.Systems medicine: evolution of systems biology from bench to bedsideEnhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.Are randomized trials obsolete or more important than ever in the genomic era?Systems biology for molecular life sciences and its impact in biomedicine.Systems engineering meets quantitative systems pharmacology: from low-level targets to engaging the host defenses.Genetics and the placebo effect: the placebome.Personalized medicine-a modern approach for the diagnosis and management of hypertension.Biomarker definitions and their applications.The genetic architecture in Saccharomyces cerevisiae that contributes to variation in drug response to the antifungals benomyl and ketoconazole.Systems biology-embedded target validation: improving efficacy in drug discovery.
P2860
Q26770167-BA91F1E0-73A9-4C4B-9128-8A9C9BE1F1D5Q26852592-A374BAA9-BB41-46BC-A657-E008DFE84A93Q27026041-ACA8B810-6EC3-4D34-B633-8872991B2460Q28603731-675A7908-61E2-44DB-91A4-E4D2D6AE2202Q30359686-F072A7D6-E19A-42ED-9EF4-9B57055F8C13Q34646772-DE218E9A-364C-4C68-A0D5-86B80CA399B5Q35688664-E586CBEB-9CB2-4664-89E6-CA7318B17651Q36342657-94888967-E635-4A9B-B4E0-48493DD8C585Q36998698-9F492904-BCDB-4790-864F-66A323F1CC4CQ38035735-762A474C-0F3F-4AF8-9A6A-DC06D735B9D7Q38380621-5A11CE17-C544-4E68-8376-30EB77E073BEQ38425277-A723F56F-3CC7-46FB-A2B3-96BF9FF6DAACQ47095825-AC045958-D104-4C0C-945A-E38FDC360846Q48500157-79688E5F-1C3B-40DC-B526-9DF0E2DBC894Q53313492-B32FD258-9935-4C33-A089-DD6B85A006FDQ54627325-3479F664-21B0-44C8-9DC5-FCF862A91286
P2860
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
@en
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine.
@nl
type
label
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
@en
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine.
@nl
prefLabel
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
@en
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine.
@nl
P2860
P356
P1476
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
@en
P2093
Scott Weiss
P2860
P304
P356
10.1002/WSBM.1173
P577
2012-05-11T00:00:00Z